Brk is coamplified with ErbB2 to promote proliferation in breast cancer
- 26 August 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (34), 12463-12468
- https://doi.org/10.1073/pnas.0805009105
Abstract
Amplification of the receptor tyrosine kinase ErbB2 is frequently observed in breast cancer. Amplification of erbB2 is also associated with multiple genomic gains and losses; however, the importance of these associated changes is largely unknown. We demonstrate that Brk, a cytoplasmic tyrosine kinase, is coamplified and coexpressed with ErbB2 in human breast cancers. ErbB2 interacts with Brk and increases its intrinsic kinase activity. Expression of Brk enhances the ErbB2-induced activation of Ras/MAPK signaling and cyclin E/cdk2 activity to induce cell proliferation of mammary 3-dimensional acini in culture. In a murine model of breast cancer, expression of Brk was found to shorten the latency of ErbB2-induced tumors by promoting cell proliferation, with no effect on protection from apoptosis. Furthermore, overexpression of Brk conferred resistance to the ability of Lapatinib, an ErbB2 kinase inhibitor, to inhibit ErbB2-induced proliferation. Thus, we identified Brk as a drug target for ErbB2-positive cancers.Keywords
This publication has 33 references indexed in Scilit:
- Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancerMolecular Oncology, 2007
- PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomasBritish Journal of Cancer, 2007
- Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesCancer Cell, 2006
- Novel patterns of genome rearrangement and their association with survival in breast cancerGenome Research, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Simultaneous over‐expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomasThe Journal of Pathology, 2005
- Epidermal Growth Factor Receptor-Dependent Regulation of Integrin-Mediated Signaling and Cell Cycle Entry in Epithelial CellsMolecular and Cellular Biology, 2004
- Regulation of the Nonreceptor Tyrosine Kinase Brk by Autophosphorylation and by AutoinhibitionPublished by Elsevier BV ,2002
- Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cellsOncogene, 2000